Oruka Therapeutics, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Oruka Therapeutics, Inc. (ORKA) is 38.51

According to Oruka Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 38.51. This represents a change of 51.65% compared to the average of 25.40 of the last 4 quarters.

Oruka Therapeutics, Inc. (ORKA) Historical Current Ratio (quarterly & annually)

How has ORKA Current Ratio performed in the past?

The mean historical Current Ratio of Oruka Therapeutics, Inc. over the last ten years is 21.04. The current 38.51 Current Ratio has changed 83.02% with respect to the historical average. Over the past ten years (40 quarters), ORKA's Current Ratio was at its highest in in the December 2023 quarter at 59.01. The Current Ratio was at its lowest in in the December 2017 quarter at 5.94.

Oruka Therapeutics, Inc. (ORKA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oruka Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oruka Therapeutics, Inc. (ORKA) Average Current Ratio

How has ORKA Current Ratio performed in the past?

The current Current Ratio of Oruka Therapeutics, Inc. (ORKA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oruka Therapeutics, Inc. (ORKA) Current Ratio vs. Peers

How is ORKA’s Current Ratio compared to its peers?

Oruka Therapeutics, Inc.’s Current Ratio is greater than AnaptysBio, Inc. (5.61), greater than Odyssey Therapeutics, Inc. (11.36), greater than MoonLake Immunotherapeutics (12.56), greater than Aclaris Therapeutics, Inc. (3.46), greater than Alumis Inc. (6.74), greater than Dianthus Therapeutics, Inc. (26.10), greater than Connect Biopharma Holdings Limited (2.37), greater than Zura Bio Limited (11.29), greater than Xencor, Inc. (6.39), greater than Attovia Therapeutics, Inc. (9.39),

Build a custom stock screener for Oruka Therapeutics, Inc. (ORKA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oruka Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oruka Therapeutics, Inc. (ORKA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oruka Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.